Last reviewed · How we verify
Rifapentine daily for 6 weeks
Rifapentine daily for 6 weeks is a Small molecule drug developed by Centers for Disease Control and Prevention. It is currently in Phase 2 development. Also known as: priftin.
At a glance
| Generic name | Rifapentine daily for 6 weeks |
|---|---|
| Also known as | priftin |
| Sponsor | Centers for Disease Control and Prevention |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB (PHASE2, PHASE3)
- One-month Latent Tuberculosis Treatment for Renal Transplant Candidates (PHASE4)
- Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis (PHASE2)
- Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis (PHASE3)
- Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study (PHASE2)
- Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention (3HP Options Implementation Trial) (NA)
- Tuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected Individuals (PHASE3)
- TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Rifapentine daily for 6 weeks CI brief — competitive landscape report
- Rifapentine daily for 6 weeks updates RSS · CI watch RSS
- Centers for Disease Control and Prevention portfolio CI
Frequently asked questions about Rifapentine daily for 6 weeks
What is Rifapentine daily for 6 weeks?
Rifapentine daily for 6 weeks is a Small molecule drug developed by Centers for Disease Control and Prevention.
Who makes Rifapentine daily for 6 weeks?
Rifapentine daily for 6 weeks is developed by Centers for Disease Control and Prevention (see full Centers for Disease Control and Prevention pipeline at /company/centers-for-disease-control-and-prevention).
Is Rifapentine daily for 6 weeks also known as anything else?
Rifapentine daily for 6 weeks is also known as priftin.
What development phase is Rifapentine daily for 6 weeks in?
Rifapentine daily for 6 weeks is in Phase 2.
Related
- Manufacturer: Centers for Disease Control and Prevention — full pipeline
- Also known as: priftin
- Compare: Rifapentine daily for 6 weeks vs similar drugs
- Pricing: Rifapentine daily for 6 weeks cost, discount & access